IMPACT OF COVID-19 ON MORTALITY AND HOSPITALIZATION IN OLDER ADULTS WITH HIP FRACTURE.

Objective: To evaluate the impact of the COVID-19 pandemic on hospital admission and mortality indicators in older adults with fractures of the proximal femur. Methods: Observational and retrospective study that took place from June 2016 to 2020. Patients of both genders who underwent surgical treatment for fractures of the proximal end of the femur, aged over 60 years, were included. Results: The population consisted of 379 patients, treated before (group 1; N = 278; 73.35%) and during the pandemic (group 2; N = 101; 26.65%). Higher mortality was observed in group 2 (N = 24; 23.8%) versus group 1 (N = 10; 3.6%), p < 0.001. The highest proportion of deaths in group 2 was maintained in patients aged 70-79 years (p = 0.011), 80-89 years (p ≤ 0.001) and > 90 years (p ≤ 0.001). In addition, the preoperative time and hospital stay were longer in group 2 compared to group 1 (p ≤ 0.001). Conclusion: The present study demonstrated that the pandemic period increased the mortality rate and the preoperative and hospitalization time in older patients with femur fractures. Thus, the pandemic has affected the care of fractures of the proximal femur in older adults, which reinforces the need to adopt measures to reduce complications and mortality. Level of Evidence II, Retrospective Study.

Objetivo: Avaliar o impacto da pandemia de COVID-19 nos indicadores de internação e mortalidade hospitalar em idosos com fraturas do fêmur proximal. Métodos: Estudo observacional e retrospectivo, que ocorreu de junho de 2016 a 2020. Foram incluídos pacientes de ambos os sexos submetidos ao tratamento cirúrgico para fratura da extremidade proximal do fêmur, com idade acima de 60 anos. Resultados: A população foi composta por 379 pacientes, atendidos antes (grupo 1; N = 278; 73,35%) e durante a pandemia (grupo 2; N = 101; 26,65%). Foi verificada maior mortalidade no grupo 2 (N = 24; 23,8%) versus o grupo 1 (N = 10; 3,6%), p < 0,001. A maior proporção de óbitos no grupo 2 se manteve nos pacientes com 70-79 anos (p = 0,011), 80-89 anos (p ≤ 0,001) e > 90 anos (p ≤ 0,001). Os períodos pré-operatório e de permanência hospitalar foram maiores no grupo 2 em comparação ao grupo 1 (p ≤ 0,001). Conclusão: Este estudo demonstrou que o período pandêmico aumentou a taxa de mortalidade e o tempo pré-operatório e de internação em pacientes idosos com fratura do fêmur. Dessa forma, a pandemia tem afetado o atendimento das fraturas do fêmur proximal em idosos, o que reforça a necessidade da adoção de medidas de redução de complicações e mortalidade. Nível de Evidência II, Estudo Retrospectivo.

Awareness of Animal Welfare and the Law among Undergraduate Students in a Brazilian Medical School.

This study aimed to evaluate medical and biomedical students' knowledge about legislation related to the use of animals in research (Arouca's Law), at the Federal University of São Paulo, Brazil. We received 62 responses to our online questionnaire of which 44 were considered valid. Only 25.3% of the students were aware of Arouca's Law and 15% of them had read it. The majority of the participants (54.5%) were not aware of the penalties established by this legislation and had not attended classes regarding animal bioethics (70.5%). Those who had attended courses about animal experimentation were less likely to begin their experiments without approval (p=0.03) and more likely not to use more animals than the number approved by the ethics committee (p=0.05). Overall, the results showed a lack of knowledge among students about animal bioethics legislation, and a failure on the part of the students' advisors to provide this information. The results highlight the need for more training on animal bioethics, better monitoring of compliance with the legislation and for courses on the subject for both students and advisors.

Impact of covid-19 on mortality and hospitalization in older adults with hip fracture / Impacto da covid-19 na mortalidade e internação de idosos com fratura do quadril

ABSTRACT Objective: To evaluate the impact of the COVID-19 pandemic on hospital admission and mortality indicators in older adults with fractures of the proximal femur. Methods: Observational and retrospective study that took place from June 2016 to 2020. Patients of both genders who underwent surgical treatment for fractures of the proximal end of the femur, aged over 60 years, were included. Results: The population consisted of 379 patients, treated before (group 1; N = 278; 73.35%) and during the pandemic (group 2; N = 101; 26.65%). Higher mortality was observed in group 2 (N = 24; 23.8%) versus group 1 (N = 10; 3.6%), p < 0.001. The highest proportion of deaths in group 2 was maintained in patients aged 70-79 years (p = 0.011), 80-89 years (p ≤ 0.001) and > 90 years (p ≤ 0.001). In addition, the preoperative time and hospital stay were longer in group 2 compared to group 1 (p ≤ 0.001). Conclusion: The present study demonstrated that the pandemic period increased the mortality rate and the preoperative and hospitalization time in older patients with femur fractures. Thus, the pandemic has affected the care of fractures of the proximal femur in older adults, which reinforces the need to adopt measures to reduce complications and mortality. Level of Evidence II, Retrospective Study.

RESUMO Objetivo: Avaliar o impacto da pandemia de COVID-19 nos indicadores de internação e mortalidade hospitalar em idosos com fraturas do fêmur proximal. Métodos: Estudo observacional e retrospectivo, que ocorreu de junho de 2016 a 2020. Foram incluídos pacientes de ambos os sexos submetidos ao tratamento cirúrgico para fratura da extremidade proximal do fêmur, com idade acima de 60 anos. Resultados: A população foi composta por 379 pacientes, atendidos antes (grupo 1; N = 278; 73,35%) e durante a pandemia (grupo 2; N = 101; 26,65%). Foi verificada maior mortalidade no grupo 2 (N = 24; 23,8%) versus o grupo 1 (N = 10; 3,6%), p < 0,001. A maior proporção de óbitos no grupo 2 se manteve nos pacientes com 70-79 anos (p = 0,011), 80-89 anos (p ≤ 0,001) e > 90 anos (p ≤ 0,001). Os períodos pré-operatório e de permanência hospitalar foram maiores no grupo 2 em comparação ao grupo 1 (p ≤ 0,001). Conclusão: Este estudo demonstrou que o período pandêmico aumentou a taxa de mortalidade e o tempo pré-operatório e de internação em pacientes idosos com fratura do fêmur. Dessa forma, a pandemia tem afetado o atendimento das fraturas do fêmur proximal em idosos, o que reforça a necessidade da adoção de medidas de redução de complicações e mortalidade. Nível de Evidência II, Estudo Retrospectivo.

Reference genes for mesangial cell and podocyte qPCR gene expression studies under high-glucose and renin-angiotensin-system blocker conditions.

BACKGROUND: Real-time PCR remains currently the gold standard method for gene expression studies. Identification of the best reference gene is a key point in performing high-quality qPCR, providing strong support for results, and performing as a source of bias when inappropriately chosen. Mesangial cells and podocytes, as essential cell lines to study diabetic kidney disease (DKD) physiopathology, demand accurate analysis of the reference genes used thus far to enhance the validity of gene expression studies, especially regarding high glucose (HG) and DKD treatments, with angiotensin II receptor blockers (e.g., losartan) being the most commonly used. This study aimed to evaluate the suitability and define the most stable reference gene for mesangial cell and podocyte studies of an in vitro DKD model of disease and its treatment. METHODS: Five software packages (RefFinder, NormFinder, GeNorm, Bestkeeper, and DataAssist) and the comparative ΔCt method were selected to analyze six different candidate genes: HPRT, ACTB, PGAM-1, GAPDH, PPIA, and B2M. RNA was extracted, and cDNA was synthesized from immortalized mouse mesangial cells and podocytes cultured in 4 groups: control (n = 5; 5 mM glucose), mannitol (n = 5; 30 mM, as osmotic control), HG (n = 5; 30 mM glucose), and HG + losartan (n = 5; 30 mM glucose and 10-4 mM losartan). Real-time PCR was performed according to MIQE guidelines. RESULTS: We identified that the use of 2 genes was the best combination for qPCR normalization for both mesangial cells and podocytes. For mesangial cells, the combination of HPRT and ACTB presented higher stability values. For podocytes, HPRT and GAPDH showed the best results. CONCLUSION: This analysis provides support for the use of HPRT and ACTB as reference genes in mouse mesangial cell studies of gene expression via real-time PCR, while for podocytes, HPRT and GAPDH should be chosen.

Association between fluid creep and infection in burned children: A cohort study.

INTRODUCTION: Aggressive fluid resuscitation has been extensively discussed after the establishment of fluid creep phenomenon as a morbidity and mortality factor in burn children. Sepsis is currently the leading cause of death in survivors of burn shock. OBJECTIVES: To evaluate the association between fluid creep and infection in burn children exposed to two different fluid resuscitation strategies with the use of albumin. METHODS: A cohort of 46 burn children with 15-45% of body surface area (BSA) admitted up to 12 h after the incident were evaluated. Patients from early albumin group (n = 23) received 5% albumin between 8 and 12 h from injury and patients from delayed albumin group (n = 23) received 5% albumin after 24 h. Outcomes analysed were development of fluid creep, length of stay in the hospital, number of surgery procedures and infection until hospital discharge. RESULTS: Compared to the delayed group, patients that received early albumin had a shorter length of stay in the hospital (p = 0.007), less fluid creep (4.3% × 56.5%) (p < 0.001), less skin graft procedure (47.8% × 78.3%) (p = 0.032) and less debridement (73.9% × 100%) (p = 0.022). Both length of stay in the hospital and fluid creep arising were associated with infection (p < 0.05). CONCLUSION: Fluid creep, surgery procedures and length of stay in hospital parameters showed better results in burn children treated with early albumin. Fluid creep and length of stay in the hospital were associated with infection, providing a negative prognosis.

Modafinil for poststroke patients: A systematic review.

INTRODUCTION: Stroke is a major cause of death and disability worldwide. The use of modafinil, a wakefulness-promoting agent, is hypothesised to benefit stroke patients. METHODS: We performed a systematic review in accordance with the Cochrane Handbook for Systematic Reviews of Interventions recommendations to assess the efficacy and safety of modafinil in poststroke patients. We prospectively registered the review protocol in PROSPERO (CRD42017078465) and reported the systematic review following the PRISMA statement. RESULTS: Two published studies (77 participants) and one ongoing randomised controlled trial, with limited methodological quality, assessed the effects of modafinil (200 mg or 400 mg) for adults from 14 days poststroke up to 3 months poststroke and fulfilled our inclusion criteria. The clinical and methodological variability between studies precluded meta-analyses. Overall, these studies showed some benefit of modafinil for fatigue, but no benefit for disability, cognition, and for subscores of stroke-specific quality of life. Data for adverse events were scarce and mortality was not considered by studies. Due to very low quality related to the evidence, we are uncertain about the effects of modafinil for all outcomes assessed by our systematic review. CONCLUSION: Based on two small randomised controlled trial, which provided very low quality evidence, the effects (benefits and harms) of modafinil for stroke patients are unclear and do not support its routinely use in clinical practice for this clinical situation. Number of Protocol registration in PROSPERO database: CRD42017078465 (available from http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017078465).

What do Cochrane systematic reviews say about interventions for treating psoriasis?

CONTEXT AND OBJECTIVE: Psoriasis is a common chronic inflammatory skin disease characterized by abnormal and increased growth of the cells that produce keratin and abnormal functioning of the immune system. We aimed to summarize the evidence available regarding interventions for patients with psoriasis. DESIGN AND SETTING: Review of systematic reviews, developed in the Discipline of Evidence-Based Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo. METHODS: A systematic search was conducted to identify Cochrane systematic reviews that fulfilled the eligibility criteria. Two authors screened titles and abstracts that had been retrieved through the search strategy. The results from all the Cochrane systematic reviews that were included were summarized and presented in a narrative synthesis. RESULTS: We included six Cochrane systematic reviews assessing interventions for treating psoriasis. The findings from high-quality evidence were that (a) etanercept reduced the psoriasis severity index, compared with placebo and (b) steroids plus vitamin D, compared with vitamin D alone, improved the skin clearance rate, as assessed by investigators, but was associated with a higher proportion of participants who dropped out due to adverse events. For all other comparisons, the quality of the evidence ranged from moderate to very low. CONCLUSION: This review included six Cochrane systematic reviews that provided evidence ranging in quality from unknown to high, regarding management of psoriasis. Further randomized controlled trials are imperative to reduce the uncertainties relating to several treatments that are already used in clinical practice.

What do Cochrane systematic reviews say about interventions for treating psoriasis?

ABSTRACT CONTEXT AND OBJECTIVE: Psoriasis is a common chronic inflammatory skin disease characterized by abnormal and increased growth of the cells that produce keratin and abnormal functioning of the immune system. We aimed to summarize the evidence available regarding interventions for patients with psoriasis. DESIGN AND SETTING: Review of systematic reviews, developed in the Discipline of Evidence-Based Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo. METHODS: A systematic search was conducted to identify Cochrane systematic reviews that fulfilled the eligibility criteria. Two authors screened titles and abstracts that had been retrieved through the search strategy. The results from all the Cochrane systematic reviews that were included were summarized and presented in a narrative synthesis. RESULTS: We included six Cochrane systematic reviews assessing interventions for treating psoriasis. The findings from high-quality evidence were that (a) etanercept reduced the psoriasis severity index, compared with placebo and (b) steroids plus vitamin D, compared with vitamin D alone, improved the skin clearance rate, as assessed by investigators, but was associated with a higher proportion of participants who dropped out due to adverse events. For all other comparisons, the quality of the evidence ranged from moderate to very low. CONCLUSION: This review included six Cochrane systematic reviews that provided evidence ranging in quality from unknown to high, regarding management of psoriasis. Further randomized controlled trials are imperative to reduce the uncertainties relating to several treatments that are already used in clinical practice.

Guidelines para publicação de estudos científicos. Parte 3: Como publicar ensaios clínicos / Guidelines for publication of scientific studies. Part 3: How to Publish Clinical Trials

Introdução: Apesar da importância do relato adequado de estudos científicos, muitos ensaios clínicos continuam sendo publicados inadequadamente, com a exposição incompleta ou ambígua de seus métodos e resultados, dificultando conclusões sólidas sobre a efetividade da intervenção estudada e sobre a reprodutibilidade dos procedimentos. Várias guidelines foram elaboradas com o objetivo de melhorar o relato e aumentar a transparência dos estudos científicos na área da saúde. Objetivos: Apresentar a ferramenta CONSORT (CONsolidated Standards of Reporting Trials), suas extensões e ferramentas derivadas, que objetivam orientar a redação de artigos baseados em ensaios clínicos. Métodos: Estudo descritivo e de análise crítica realizado na Disciplina de Medicina Baseada em Evidências da Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (Unifesp), com busca da literatura. Resultados: A busca inicial resultou em 18 ferramentas. Foram incluídas a ferramenta CONSORT original e 17 extensões e ferramentas derivadas, elaboradas para desenhos ou situações clínicas mais específicos. Conclusão: O relato de estudos científicos deve ser realizado de forma clara, transparente e completa, ou seja, apresentar todas as informações que são necessárias para a interpretação e a reprodutibilidade do estudo, sem ocultação de detalhes importantes. A ferramenta CONSORT e suas extensões derivadas são essenciais para a adequação do relato de ensaios clínicos e seu uso deve ser incentivado.